154 related articles for article (PubMed ID: 16963274)
1. The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.
Ramakers BP; Riksen NP; Rongen GA; van der Hoeven JG; Smits P; Pickkers P
Cytokine; 2006 Jul; 35(1-2):95-9. PubMed ID: 16963274
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
4. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
6. Adenosine inhibits the release of interleukin-1beta in activated human peripheral mononuclear cells.
Sipka S; Kovács I; Szántó S; Szegedi G; Brugós L; Bruckner G; József Szentmiklósi A
Cytokine; 2005 Aug; 31(4):258-63. PubMed ID: 16026998
[TBL] [Abstract][Full Text] [Related]
7. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
8. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
Remer KA; Brcic M; Sauter KS; Jungi TW
J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029
[TBL] [Abstract][Full Text] [Related]
9. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
[TBL] [Abstract][Full Text] [Related]
10. Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages.
Franchini M; Schweizer M; Mätzener P; Magkouras I; Sauter KS; Mirkovitch J; Peterhans E; Jungi TW
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):37-49. PubMed ID: 16216336
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of in vitro tumor cell proliferation by cytokines induced by combinations of TLR or TLR and TCR agonists.
Ghosh TK; Mickelson DJ; Lipson KE; Alkan SS
Int Immunopharmacol; 2007 Nov; 7(11):1471-82. PubMed ID: 17761351
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors.
Weaver LK; Pioli PA; Wardwell K; Vogel SN; Guyre PM
J Leukoc Biol; 2007 Mar; 81(3):663-71. PubMed ID: 17164428
[TBL] [Abstract][Full Text] [Related]
13. Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated.
Takahashi HK; Iwagaki H; Hamano R; Wake H; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
Br J Pharmacol; 2007 Mar; 150(6):816-22. PubMed ID: 17310143
[TBL] [Abstract][Full Text] [Related]
14. Menstrual cycle influences Toll-like receptor responses.
Dennison U; McKernan DP; Scully P; Clarke G; Cryan J; Dinan T
Neuroimmunomodulation; 2012; 19(3):171-9. PubMed ID: 22262081
[TBL] [Abstract][Full Text] [Related]
15. Differential regulatory effects of adenosine on cytokine release by activated human monocytes.
Bouma MG; Stad RK; van den Wildenberg FA; Buurman WA
J Immunol; 1994 Nov; 153(9):4159-68. PubMed ID: 7930619
[TBL] [Abstract][Full Text] [Related]
16. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
Roelofs MF; Wenink MH; Brentano F; Abdollahi-Roodsaz S; Oppers-Walgreen B; Barrera P; van Riel PL; Joosten LA; Kyburz D; van den Berg WB; Radstake TR
Ann Rheum Dis; 2009 Sep; 68(9):1486-93. PubMed ID: 18765427
[TBL] [Abstract][Full Text] [Related]
17. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles and function of Toll-like receptors in human corneal epithelia.
Wu XY; Gao JL; Ren MY
Chin Med J (Engl); 2007 May; 120(10):893-7. PubMed ID: 17543179
[TBL] [Abstract][Full Text] [Related]
19. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
Krumbiegel D; Zepp F; Meyer CU
Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
[TBL] [Abstract][Full Text] [Related]
20. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.
Kox M; van Velzen JF; Pompe JC; Hoedemaekers CW; van der Hoeven JG; Pickkers P
Biochem Pharmacol; 2009 Oct; 78(7):863-72. PubMed ID: 19576181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
